Résultats de la recherche - 23 results
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
Paraskevaidis, Evangelos; M. Arbyn; Flanagan, James; Veroniki, Areti; Kyrgiou, Maria Source: BMJ Open, Volume 13, Issue 6 (2023) Keywords: Diagnostic Tests, Routine Dna DNA Methylation Early Detection of Cancer ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
Cervical Dysplasia Uterine Cervical Neoplasms Abstract: AIM: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex ...
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.
Arbyn Source: Virol J, Volume 20, Issue 1 (2023) Keywords: Clinical Laboratory Techniques COVID-19 COVID-19 Testing Humans Molecular Diagnostic Techniques Pandemics SARS-CoV-2 Sensitivity and Specificity ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
efficiency and PCR inhibition. 1300 VALGENT-2 study samples (from women aged 20-60 attending the Scottish cervical cancer screening program) were tested with the index assay and the GP5 +/6+ PCR enzyme ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
HPV SCREENING self-sampling self-sampling kits Abstract: BACKGROUND: Human papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among ...
The European response to the WHO call cervical cancer as a public health problem
achieve 70% of screening coverage in the target age group, providing also HPV testing on self‐samples for non‐ or under‐screened women; and to manage 90% of screen‐positive women. To guide member states, ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
powerful tools are available for primary and secondary prevention of cervical cancer, among which prophylactic HPV vaccines, and screening using validated HPV tests for women—including some tests that can be ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
can be triaged accurately with a high-risk human papillomavirus (hrHPV) test to identify those who need a referral. However, the triage of low-grade squamous intraepithelial lesion (LSIL) with hrHPV ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
repeat invitation letters or an HPV self-collection kit. Colposcopy should be carried out for further investigation if cytology findings are Pap II-p and HPV test results are positive or if the results of ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
HPV-based screening. Co-testing can also be carried out. Women between the ages of 20 and 35 should have cytological screening every 2 years. Health Topics: Quality of healthcare Cancer Qualité des soins de ...